Table 2.
Colon cancer | Rectal cancer | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percentiles | COLON Multivariate quantile regression | Percentiles | RECTUM Multivariate quantile regression | |||||||||||||||
50th | 75th | 90th | 50th percentile | 75th percentile | 50th | 75th | 90th | 50th percentile | 75th percentile | |||||||||
Adj. interval | 95% CI | p-value | Adj. interval | 95% CI | p-value | Adj. interval | 95% CI | p-value | Adj. interval | 95% CI | p-value | |||||||
Reference groupa | 29.7 | 1.7, 44.7 | 97.3 | 49.4, 150.6 | 38.0 | 19.8, 56.2 | 155.0 | 65.0, 245.0 | ||||||||||
Age group | ||||||||||||||||||
<45 | 131 | 348 | 666 | 71.5 | −56.3, 199.4 | 0.373 | 234.7 | 74.0, 395.4 | 0.017 | 43 | 108 | 386 | 32.0 | −12.7, 76.7 | 0.657 | 63.0 | −136.1, 262.1 | 0.098 |
45–54 | 88 | 321 | 558 | 40.5 | −9.5, 90.6 | 0.234 | 178.3 | 6.6, 350.0 | 0.205 | 63 | 257 | 506 | 47.5 | 8.2, 86.8 | 0.377 | 175.0 | −46.1, 396.1 | 0.765 |
55–64 | 65 | 237 | 512 | 58 | 259 | 498 | ||||||||||||
65–74 | 71 | 306 | 541 | 23.7 | −16.9, 64.3 | 0.959 | 155.0 | 37.6, 272.4 | 0.106 | 55 | 211 | 444 | 32.0 | −1.4, 65.4 | 0.438 | 97.0 | −77.1, 271.1 | 0.176 |
75–84 | 112 | 401 | 611 | 58.7 | 13.9, 103.5 | 0.003 | 240.7 | 125.9, 355.4 | <0.001 | 106 | 376 | 566 | 63.5 | 12.6, 114.4 | 0.127 | 225.0 | 40.4, 409.6 | 0.147 |
85+ | 176 | 457 | 626 | 107.0 | 32.4, 181.6 | 0.002 | 263.0 | 127.9, 398.1 | <0.001 | 140 | 433 | 581 | 53.0 | −20.3, 126.3 | 0.594 | 233.0 | 38.8, 427.2 | 0.142 |
Sex | ||||||||||||||||||
Male | 87 | 337 | 561 | 66 | 266 | 520 | ||||||||||||
Female | 108 | 374 | 599 | 25.7 | −11.1, 62.5 | 0.749 | 128.3 | 35.7, 221.0 | 0.187 | 79 | 342 | 551 | 57.0 | 22.2, 91.8 | 0.025 | 199.0 | 60.6, 337.4 | 0.075 |
Deprivation quintile | ||||||||||||||||||
1 (Lowest) | 87 | 336 | 580 | 71 | 272 | 521 | ||||||||||||
2 | 98 | 370 | 600 | 29.5 | −13.8, 72.8 | 0.569 | 147.7 | 24.2, 271.1 | 0.200 | 73 | 325 | 545 | 44.0 | 2.0, 86.0 | 0.621 | 155.0 | 1.7, 308.3 | 1 |
3 | 81 | 314 | 545 | 22.5 | −18.8, 63.9 | 0.947 | 114.3 | −0.9, 229.6 | 0.664 | 59 | 294 | 534 | 26.5 | −12.3, 65.3 | 0.274 | 194.0 | 30.8, 357.2 | 0.296 |
4 | 93 | 381 | 588 | 34.9 | −12.4, 82.1 | 0.375 | 123.0 | 2.0, 244.0 | 0.522 | 53 | 282 | 523 | 28.0 | −14.7, 70.7 | 0.424 | 133.0 | −17.4, 283.4 | 0.475 |
5 (highest) | 135 | 424 | 616 | 75.5 | 7.4, 143.7 | 0.028 | 215.0 | 98.0, 332.0 | 0.001 | 83 | 270 | 523 | 42.0 | −3.3, 87.3 | 0.772 | 163.0 | 12.0, 314.0 | 0.797 |
Charlson comorbidityb | ||||||||||||||||||
0 | 74 | 289 | 542 | 50 | 218 | 481 | ||||||||||||
1 | 96 | 370 | 588 | 46.2 | 1.4, 91.0 | 0.053 | 186.3 | 76.8, 295.9 | 0.004 | 130 | 376 | 549 | 110.5 | 45.6, 175.4 | 0.002 | 294.0 | 137.1, 450.9 | <0.001 |
2 | 161 | 400 | 617 | 119.9 | 40.6, 199.2 | 0.001 | 200.7 | 73.3, 328.0 | 0.010 | 146 | 408 | 598 | 121.0 | 29.1, 212.9 | 0.027 | 397.0 | 206.0, 588.0 | <0.001 |
3+ | 204 | 504 | 648 | 182.0 | 103.6, 260.5 | <0.001 | 266.7 | 140.9, 392.4 | <0.001 | 141 | 473 | 638 | 173.5 | 32.2, 314.8 | 0.031 | 366.0 | 210.6, 521.4 | <0.001 |
Symptoms | ||||||||||||||||||
CIBH or RB | 64 | 257 | 548 | 50 | 228 | 517 | ||||||||||||
Test anaemia | 92 | 334 | 557 | 64.4 | 25.1, 103.6 | <0.001 | 165.0 | 52.5, 277.5 | 0.040 | 129 | 367 | 537 | 95.5 | 11.3, 179.7 | 0.088 | 259.0 | 86.0, 432.0 | 0.014 |
Non red-flag | 159 | 451 | 627 | 147.7 | 87.5, 207.9 | <0.001 | 272.3 | 166.3, 378.4 | <0.001 | 128 | 384 | 551 | 111.0 | 47.0, 175.0 | 0.002 | 310.0 | 158.9, 461.1 | <0.001 |
aThe reference group corresponds to 55–64 year old men, in the least deprived group, without comorbidities, with change in bowel habit (CIBH) or rectal bleeding (RB).
bCharlson comorbidity score.